Cargando…

Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain

OBJECTIVES: To evaluate the cost-effectiveness of direct-acting antiviral (DAAs) treatment versus non-treatment in prisoners awaiting treatment for chronic hepatitis C (CHC) and to analyse the clinical and economic impact of the treatment on liver complications and mortality. MATERIAL AND METHOD: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marco, A, Domínguez-Hernández, R, Casado, MA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Sanidad Penitenciaria 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537362/ https://www.ncbi.nlm.nih.gov/pubmed/32697276 http://dx.doi.org/10.18176/resp.00012

Ejemplares similares

Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain
por: Esteban, Rafael, et al.
Publicado: (2022)

Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis
por: Kwon, Jisoo A., et al.
Publicado: (2021)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?
por: Marco, A, et al.
Publicado: (2019)

Healthcare value of implementing hepatitis C screening in the adult general population in Spain
por: Buti, María, et al.
Publicado: (2018)

Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
por: Sutton, Andrew J, et al.
Publicado: (2006)

Incidence and molecular epidemiology of hepatitis C virus reinfection in prisons in Catalonia, Spain (Re-HCV study)
por: Saludes, Verónica, et al.
Publicado: (2023)

Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence
por: Ledesma, Francisco, et al.
Publicado: (2020)

Author Correction: Incidence and molecular epidemiology of hepatitis C virus reinfection in prisons in Catalonia, Spain (Re-HCV study)
por: Saludes, Verónica, et al.
Publicado: (2023)

Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022)

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
por: Navarro, F., et al.
Publicado: (2020)

Hepatitis C in Israeli prisons: status report
por: Michaeli, Niv, et al.
Publicado: (2020)

Real-life experience of hepatitis C treatment in a Spanish prison
por: Tejera-Pérez, Rosa Juana, et al.
Publicado: (2022)

Diseases and access to treatment by the Peruvian prison population: an analysis according to gender
por: Hernández-Vásquez, A, et al.
Publicado: (2020)

Evaluation of the impact of family relations on prisoners’ health in Spain
por: Caravaca-Sánchez, F, et al.
Publicado: (2020)

COVID-19 and Prisons in Spain: is there any good news?
por: Martín, Vicente
Publicado: (2022)

Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison
por: Okafor, Ifeyinwa M., et al.
Publicado: (2020)

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
por: Alsina, Laia, et al.
Publicado: (2021)

Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
por: Zhang, Sai, et al.
Publicado: (2015)

Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C
por: García-Herola, Antonio, et al.
Publicado: (2021)

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
por: Tsai, Yu-Chi, et al.
Publicado: (2023)

Hepatitis C Prevalence Among Iranian Female prisoners
por: Abdi, Fatemeh
Publicado: (2012)

Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration
por: Crowley, D., et al.
Publicado: (2018)

Hepatitis C testing, treatment and prevention in low- and middle-income country prisons
por: Tucker, Joseph D., et al.
Publicado: (2022)

Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
por: Juanbeltz, Regina, et al.
Publicado: (2018)

Telemedicine and specialised consultations in prisons. The example of HCV chronic hepatitis
por: Fernández Rodríguez, C, et al.
Publicado: (2019)

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
por: Liu, Shan, et al.
Publicado: (2011)

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
por: Sanchez-de la Rosa, Rainel, et al.
Publicado: (2013)

Acquiring hepatitis C in prison: the social organisation of injecting risk
por: Treloar, Carla, et al.
Publicado: (2015)

The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey
por: Keten, Derya, et al.
Publicado: (2016)

Incidence, prevalence and risk factors for hepatitis C in Danish prisons
por: Søholm, Jacob, et al.
Publicado: (2019)

Management of Hepatitis C in Delaware Prisons: : Approaching Microenvironmental Eradication
por: Mazur, William P.
Publicado: (2019)

Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective
por: Crowley, Des, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain
por: Ojeda, B, et al.
Publicado: (2003)

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
por: Pfeil, Alena M., et al.
Publicado: (2015)

Modelling cost-effectiveness of syphilis detection strategies in prisoners: exploratory exercise in a Chilean male prison
por: Castillo-Laborde, Carla, et al.
Publicado: (2021)

Burnout syndrome and work satisfaction in professionals of social work in prisons of Spain
por: Sánchez F, Caravaca, et al.
Publicado: (2018)

A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons
por: Lafferty, Lise, et al.
Publicado: (2018)

The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons
por: Richter, Vered, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0l5p93m8b0in8s5r161crno35v